Category:
Description:
Indications:
-
Genital
herpes treatment and prophylaxis
-
Mucosal
and cutaneous herpes simplex (HSV-1 and HSV-2) treatment and
prophylaxis
-
Varicella-zoster
(chickenpox & shingles)
Precautions:
-
Pregnancy
category C
-
Dosing
modification is required for patients with impaired renal function.
-
Avoid
sexual contact when genital lesions are present.
-
Medication
treatment is not a cure for viral infection.
-
Do
not exceed recommended dose.
-
Initiate
therapy at earliest signs of symptoms.
-
Use
rubber gloves or a finger cot when applying topical cream to active
lesions, so as not to inoculate other areas.
Adverse
Reactions (Side Effects):
|
Dosage:
Administered
as an oral tablet, capsule, topical cream or injection
Parenteral (avoid rapid IV, IM or SQ injections, administer via slow IV infusion):
Mucosal
and cutaneous HSV infections:
Varicella-zoster
(shingles) infections:
Herpes
simplex encephalitis:
Oral:
Herpes
simplex:
-
Initial
infection: 200mg q4h (5 times a day) for 10 days
-
Chronic
suppression: 400mg bid for 12 months
-
Intermittent
therapy: 200mg q4h (5 times a day) for 5 days
Herpes
zoster, acute treatment
Chickenpox
Topical:
|
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300 Military
Obstetrics & Gynecology
© 2003, 2004, 2005, 2006 Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
Other
Brookside Products |